STOCK TITAN

Silk Road Medical to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Silk Road Medical, Inc. (NASDAQ: SILK) announced it will report its financial results for Q4 and full year 2020 on March 1, 2021, after market close. A conference call will follow at 1:30 p.m. PT / 4:30 p.m. ET, accessible via phone and webcast. Silk Road Medical specializes in reducing stroke risks with its TransCarotid Artery Revascularization (TCAR) procedure, aimed at treating carotid artery blockages. Investors can find additional information on the company’s website and through investor relations contacts.

Positive
  • Silk Road Medical is focused on reducing stroke risks with its proven TCAR procedure.
Negative
  • None.

SUNNYVALE, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the fourth quarter and full year 2020 after market close on Monday, March 1, 2021. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by dialing (844) 883-3861 for domestic callers or (574) 990-9820 for international callers, using conference ID: 3554549. A live and archived webcast of the event will be available at https://investors.silkroadmed.com/.    

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company’s flagship procedure, TransCarotid Artery Revascularization (TCAR), is clinically proven to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Caroline Paul
Gilmartin Group
investors@silkroadmed.com


FAQ

When will Silk Road Medical report its financial results for 2020?

Silk Road Medical will report its financial results for the fourth quarter and full year 2020 on March 1, 2021.

What time is the conference call for Silk Road Medical's financial results?

The conference call will be held at 1:30 p.m. PT / 4:30 p.m. ET on March 1, 2021.

How can I listen to the conference call for Silk Road Medical?

You can listen to the conference call by dialing (844) 883-3861 for domestic or (574) 990-9820 for international callers, using conference ID: 3554549.

What is the focus of Silk Road Medical?

Silk Road Medical focuses on reducing the risk of stroke with its TransCarotid Artery Revascularization (TCAR) procedure.

Silk Road Medical, Inc.

NASDAQ:SILK

SILK Rankings

SILK Latest News

SILK Stock Data

1.12B
40.63M
4.15%
97.46%
7.75%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SUNNYVALE